Table of Contents

Citalopram (Celexa)

Primer

Pharmacokinetics

Pharmacokinetics of Citalopram

Citalopram: Cytochrome P450 Metabolism

Substrate of (Metabolized by)
Induces
Inhibits

Pharmacodynamics

Mechanism of Action

Toxicity

Indications

Citalopram vs. Escitalopram

Recommended daily dose ranges for citalopram and escitalopram

Population Citalopram Escitalopram
Adult 18-65 years
without risk factors
• Starting: 20mg
• Maximum: 40mg
• Starting: 10mg
• Maximum: 20mg
Adult >65 years or
impaired hepatic
function
• Starting: 10mg
• Maximum: 20mg
• Starting: 5mg
• Maximum: 10mg
Taking omeprazole* • Starting: 20mg
• Maximum: 20mg
• Starting: 5mg
• Maximum: 10mg

Dosing

Dosing for Citalopram

Starting 10 mg PO daily for 2 weeks
Titration Increase by 10 mg every 1 to 2 weeks depending on tolerability
Maximum 40 mg (previously approved for up to 60 mg/day, but no longer due to QTc concerns)
Taper Tapering/Switching Antidepressants

Formulations

Monitoring

Contraindications

Absolute

Relative

Drug-Drug Interactions

Side Effects

Adverse Events

QTc Prolongation

Citalopram is linked to QTc prolongation. It is thought that SERT-R is the cause of QTc prolongation in dose dependent fashion

Clinical Pearls

Special Populations

Geriatric

Pediatric

Obstetric and Fetal

Medically Ill

Resources